An
Alternative Practice Model for Community Pharmacies: Taking Control of
Your Prescription Work Flow by Providing Better Adherence Management
Please
read through the following information and click continue.
ACPE Universal Program Number:
207-000-08-124-H05-P
and 207-000-08-124-H05-T
Release
Date: October 13, 2008
Expiration Date: October 13, 2011
Statement
of Need
The
current pharmacy market is characterized by higher volume, more
complicated therapies and a great need for patient counseling and this
shows no signs of stopping. As the Medicare population continues to
grow with their multiple medications and higher need for counseling the
pharmacy’s most rapidly diminishing resource could well be the actual
time you have to take care of your patients and your business.
Given the 80/20 rule that 20% of your patients require 80% of your time and account for 80% of your business, one answer to the growing pressure on your pharmacy’s time and resources lies in controlling pharmacy workflow by improving your adherence management. This session will provide a template and tools for modifying your practice, consolidating refills for patients with multiple medications and managing your workflow to give you more time to counsel your patients and manage your business.
Successful pharmacy peers who have modified their practice to capitalize on this system will share their challenges, steps and successes, plus simple tools that you can use right away to make a difference for you and your patients.
Learning
Objectives
Upon
successful completion of this activity, the pharmacist should be able
to:
- List three adherence practice modifications that can alter workflow.
- Outline steps to consolidate patient refill dates.
- Discuss the improvements to patient care that result from improving workflow management.
Target
Audience
The
target market for this activity is pharmacists and pharmacy technicians.
Instructions
for Participation
To
receive a certificate of completion that indicates your eligibility for
continuing education credit, you must:
- Review the content of the activity.
- Successfully complete the post-test (70% or higher).
- You will have two (2) opportunities to successfully complete the activity.
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee
There
is no fee for this activity.
Accreditation
Pharmacists
NCPA is accredited by the Accreditation Council
for Pharmacy Education as a provider of continuing pharmacy education.
This program will provide 1.5 contact hours (.15 CEUs) of continuing
pharmacy education credit under the number 207-000-08-124-H05-P
and 207-000-08-124-H05-T.
Faculty
Benjamin
Banahan III, PhD (click here to view bio)
(Co-Principal Investigator)
Research Professor
Center for Pharmaceutical Marketing and Management
Professor
Department of Pharmacy Administration
The University of Mississippi
University, Mississippi
Erin
Holmes, PharmD, PhD (click here to view bio)
Assistant Professor – Pharmacy Administration
Research Assistant Professor – Research Institute of Pharmaceutical
Sciences
The University of Mississippi
University, Mississippi
Bob
Lomenick, RPh (click here to view bio)
Owner
Tyson Drug Co.
Holly Springs, Mississippi
Stanley Devine, RPh (click here to view bio)
Owner
PharmNet, Inc.
Winona, Mississippi
Disclosure
Declaration
It
is the policy of the National Community Pharmacists Association (NCPA)
to ensure independence, balance, objectivity, scientific rigor, and
integrity in all of their continuing education activities.
The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
Software Requirements
|
PC *Required to view Printable PDF Version |
MAC |